T45.622D Poisoning by hemostatic drug, intentional self-harm, subsequent encounter

Name of the Condition

• Poisoning by hemostatic drug, intentional self-harm, subsequent encounter (ICD-10 code: T45.622D)

Summary

This condition involves intentional self-harm resulting from hemostatic drug exposure, representing a subsequent encounter for the adverse event. It includes toxic effects or adverse reactions due to deliberate ingestion or administration of these agents, which are used to control bleeding. The subsequent encounter indicates ongoing care following the initial treatment for the self-harm incident.

Causes

Intentional self-harm may occur from deliberate ingestion or administration of hemostatic drugs. This can result from suicidal ideation, misuse, or intentional overdose of these medications. Underlying factors may include mental health conditions, substance use disorders, or access to these drugs. The subsequent encounter reflects continued management of the poisoning and its consequences.

Risk Factors

• History of suicidal behavior or mental health disorders.
• Access to hemostatic medications (e.g., in healthcare or home settings).
• Concurrent substance use or intoxication.
• Prior self-harm attempts or ideation.
• Social or environmental stressors contributing to self-harm.

Symptoms

• Excessive clotting (e.g., deep vein thrombosis, pulmonary embolism) or paradoxical bleeding.
• Gastrointestinal or intracranial hemorrhage.
• Organ dysfunction (e.g., renal or hepatic impairment).
• Neurological symptoms (e.g., confusion, seizures, coma).
• Signs of systemic toxicity (e.g., hypotension, tachycardia).

Diagnosis

Diagnosis involves clinical evaluation of symptoms, medication history, and toxicology screening. Healthcare providers assess the intent of self-harm, review drug levels, and conduct imaging or lab tests to identify complications. Documentation of the subsequent encounter confirms ongoing care after the initial treatment phase.

Treatment Options

Treatment focuses on stabilizing the patient, managing complications, and addressing the underlying self-harm. This may include antidotes, supportive care (e.g., transfusions, dialysis), and psychiatric evaluation. Long-term management involves mental health support and safety planning to prevent recurrence.

Prognosis and Follow-Up

Prognosis depends on the severity of poisoning, timely intervention, and mental health support. Follow-up care includes monitoring for complications, medication adjustments, and ongoing psychiatric care. Regular assessments help address residual effects and reduce future self-harm risk.

Complications

• Severe bleeding or thrombotic events.
• Organ failure (e.g., kidney, liver).
• Neurological damage or cognitive impairment.
• Psychological sequelae (e.g., depression, PTSD).
• Recurrent self-harm or overdose.

Lifestyle & Prevention

• Secure storage of hemostatic medications to limit access.
• Mental health support and crisis intervention for at-risk individuals.
• Education on medication safety and self-harm prevention.
• Regular follow-up with healthcare providers for ongoing care.
• Family or caregiver involvement in monitoring and support.

When to Seek Professional Help

Seek immediate medical attention if symptoms of poisoning (e.g., uncontrolled bleeding, severe pain, confusion) occur. Contact mental health professionals for suicidal ideation or self-harm behaviors. Prompt care reduces complications and supports recovery.

Tips for Medical Coders

Document the intent of self-harm clearly, including any statements or evidence of deliberate action. Specify the subsequent encounter to indicate ongoing care after the initial treatment phase. Ensure documentation aligns with clinical findings and supports the use of T45.622D.